DONATE

2014

Breastcancer.org strives to bring you updates on the latest breast cancer research through its Research News program. Look for updates from the American Society of Clinical Oncology Annual Meeting in June and from the San Antonio Breast Cancer Symposium in December. Medical experts at Breastcancer.org provide easy-to-understand summaries of what the research means for YOU.

Was this article helpful? Yes / No

Last modified on January 15, 2014 at 4:16 AM

Bone Health
Chemotherapy
Complementary and Holistic Therapies
Day-to-Day Matters
Dealing with Cancer Fear
Diagnosis
Exercise
Fertility and Pregnancy
Genetic Testing
Hormonal Therapy
Immunotherapy
Male Breast Cancer
Menopausal Symptoms
Metastatic Breast Cancer
Nutrition
Planning Your Treatment
Radiation Therapy
Reconstruction
Risk Factors
Screening and Testing
Side Effects
Surgery
Targeted Therapy
Ethnicity
Breast Cancer’s Hormone Receptor and HER2 Status Can Change After Diagnosis
Research News by Date
About 25% of Women Need More Surgery After Lumpectomy
More U.S. Women Choosing Mastectomy Over Lumpectomy for Early-Stage Disease
Common Blood Pressure Medicine Doesn’t Increase Breast Cancer Risk
Screening Based on Risk for Women in Their 40s Likely Misses Most Breast Cancers
Device That Standardizes Pressure During Mammograms Could Reduce Pain
Study Suggests Earlier Research on CYP2D6 Is Flawed
Aromasin Plus Ovarian Suppression Reduces Recurrence Risk Better Than Tamoxifen Plus Ovarian Suppression in Premenopausal Women Who’ve Received Chemotherapy (with video)
Low-Fat Diet and Weight Loss Improves Survival in Some Women
Male Breast Cancer Is Different in Terms of Biology and Outcomes
Abraxane Offers More Benefits Than Taxol When Given Before Surgery to Treat Early-Stage Disease
Tamoxifen’s Benefits Long-Lasting for High-Risk Women
Faslodex Offers Better Survival Than Arimidex as First Treatment for Women With Advanced-Stage Disease
Oncotype DX DCIS Test Helps Predict Risk of Recurrence
Certain Benign Breast Disease Increases Risk More Than Thought
Herceptin Plus Taxol Reduces Recurrence Risk of Small HER2-Positive Breast Cancers
New Gene Seems Especially Active in Triple-Negative Breast Cancer
Use of Shorter Radiation Regimen Triples, but Still Underused Experts Say
High Levels of Immune Cells in HER2-Positive Cancers May Mean Tumors Need Only Chemotherapy
Risk of Leukemia After Chemotherapy or Radiation Therapy for Early-Stage Breast Cancer Higher Than Thought
Palbociclib (Also Called Ibrance) Approved by FDA
Breast Cancer Stage at Diagnosis, Survival Rates Varies by Race, Ethnicity
Halaven No Better Than Xeloda for Previously Treated Metastatic Disease
Ultrasound After Chemotherapy Before Surgery Can Help Doctors Decide How Many Lymph Nodes to Remove
Many Women Diagnosed With Breast Cancer Know Little About Their Condition
New Model Offers Better Breast Cancer Risk Estimate for Black Women
New Genetic Abnormalities Linked to Breast Cancer in Black Families
Many Women Don’t Get Recommended Radiation After Mastectomy to Remove Locally Advanced Disease
Mammogram Rates Declined 3 Years After Unadopted Task Force Recommendations
Household Net Worth Has Big Effect on Whether Women Finish Hormonal Therapy Treatment
Chemotherapy Before Surgery Increases Likelihood of Lumpectomy
Zoladex During Chemotherapy Can Help Preserve Fertility in Women Diagnosed With Early-Stage, Hormone-Receptor-Negative Disease
Oncotype DX Test Adopted Quickly, Used Appropriately
Family History of Prostate Cancer Seems to Increase Breast Cancer Risk
Herceptin Plus Chemotherapy Better Than Tykerb Plus Chemotherapy as First Treatment for Metastatic HER2-Positive Disease
Study Looks at Accuracy of Breast Biopsy Results
Text Message Reminders Help More British Women Keep Screening Appointments
Starting Palliative Care Earlier Rather Than Later Benefits Caregivers and People With Advanced-Stage Disease
Specific Type of Stress Management Helps Improve Mood and Quality of Life Long-Term
Most Women Diagnosed With Early-Stage Disease Don’t Have More Than a Few Lymph Nodes Removed
Study Suggests Link Between Diabetes, More Advanced-Stage Breast Cancer
Combining Risk of Common Genetic Variants May Lead to Better Breast Cancer Risk Assessment
Risk of Breast, Ovarian Cancer May Vary Depending on Type and Location of BRCA Mutation
If Genomic Analysis Is Done, Genes of Both Cancer Tumor and Normal Tissue Need to Be Analyzed
Hormone Replacement Therapy’s Effect on Breast Cancer Risk Changes Over Time
Women With Abnormal BRCA1 Gene Benefit From Ovary Removal
Being Diagnosed With Cancer Affects How Brain Works
Specific Cell Actions May Help Explain Differences in Outcomes Between Black and White Women Diagnosed With Breast Cancer
Gene Abnormality Linked to Breast Cancer in Polish and French-Canadian Women
Exercising During Chemotherapy Reduces Side Effects
Chemo Brain Is Real, Researchers Say
Study Finds Link Between Breastfeeding and Lower Risk of Recurrence
Young Survival Coalition Research Think Tank Releases Research Priorities for Breast Cancer in Young Women
Immune Cells in Early-Stage, HER2-Positive Breast Cancer Cells Linked to Better Response to Treatment Before Surgery
White and Black Men With Breast Cancer Receive Similar Treatment but Black Men Have Worse Outcomes
Another Study Suggests 3-D Mammograms Find More Cancers
Both Fish Oil and Placebo Ease Joint Pain in Women Taking Aromatase Inhibitors
Men With High Estrogen Levels Could Have Increased Breast Cancer Risk
Some Older Women Treated With Hormonal Therapy May Not Need Radiation Therapy
Study Suggests Not All Women With Dense Breasts Have Higher Cancer Risk
Black Women Have Worse Breast Cancer Survival Rates Compared to Whites and Hispanics
Slow, Progressive Weight Lifting Helps Survivors Keep Physical Function
Older Women Treated With Herceptin Need Better Heart Monitoring
Study Suggests Minority Women Less Involved in Selecting Surgeon, Hospital
Family History of Breast Cancer Doesn’t Mean Worse Outcomes for Young Women
Why Do People Use Complementary and Holistic Therapies?
Lifestyle Changes Result in Weight Loss for Women Who’ve Been Treated for Breast Cancer
Removing More Tissue Reduces Need for More Surgery After Lumpectomy
Arimidex Reduces DCIS Recurrence Risk More Than Tamoxifen
Ibrance Offers Benefits as Second-Line Treatment for Advanced-Stage Disease
Avastin Helps Reduce Cancer Growth but Increases Side Effects and Doesn’t Improve Survival
All Bisphosphonates Reduce Recurrence Risk the Same Amount
No Link Between Blood Pressure Medicine and Breast Cancer
Prolia Dramatically Lowers Risk of Breaking Bones in Women Taking Aromatase Inhibitors
International Agency for Research on Cancer Releases Breast Cancer Screening Special Report
Study Confirms Taxol Better Than Ixempra or Abraxane for Locally Advanced or Metastatic Disease
Choice of Surgeon and Hospital Affects Type of Lymph Node Surgery in Women Diagnosed With DCIS
Study Suggests Link Between DDT Exposure in Womb and Higher Breast Cancer Risk
Lumpectomy Rates Up, but Barriers Still Exist
Freezing Embryos Helps Women Conceive After Breast Cancer Treatment
Certain Antidepressants Taken for Hot Flashes Linked to Higher Risk of Breaking a Bone
Partial-Breast Radiation Offers Survival, Recurrence Rates Similar to Whole-Breast Radiation After Lumpectomy
Urea Cream Prevents Hand-Foot Syndrome Better Than New Mapisal Ointment
Women Who’ve Been Diagnosed With Breast Cancer More Likely to Gain Weight Than Women Who Haven’t Been Diagnosed
Support Tool Helps Women Emotionally Adjust After Being Diagnosed With Early-Stage Disease
ASCO Issues Guidelines on Using Biomarkers to Make Treatment Decisions in Women Diagnosed With Metastatic Disease
New Technique Allows More Women to Have Nipple-Sparing Mastectomy
Exercising 300 Minutes Per Week Leads to More Fat Loss in Postmenopausal Women
Another Study Confirms Oncotype DX DCIS Recurrence Score Predicts Recurrence
Does End-Stage Chemotherapy Improve Quality of Life?
Common Chemicals May Act Together to Increase Cancer Risk
Lidocaine May Help Ease Painful Intercourse After Breast Cancer Treatment
Starting Mammograms at Age 40 Instead of 50 Saves Lives
Older and Heavier Women More Likely to Have Heart Problems When Treated With Anthracycline Chemotherapy
Fewer Women Dying From Breast Cancer
More Young Men Than Young Women Take Steps to Preserve Fertility Before Cancer Treatment
Radiation to Regional Lymph Nodes Reduces Recurrence but Doesn’t Improve Survival
Shorter Radiation Regimen Causes Fewer Side Effects, Offers Better Quality of Life Than Traditional Regimen
Study Says Breast Cancer Prevention Must Begin Early in Life
Women Older Than 80 Less Likely to Benefit From Chemotherapy
Research Suggests Risk Continues to Increase as Weight Goes Up
Study Looks at How Many Women Die From Breast Cancer After a DCIS Diagnosis
History of Benign Breast Disease Added to Risk Assessment Tool
Study Looks for Link Between Oncotype DX Test Use and Chemotherapy in Older Diagnosed Women
Music Therapy Eases Anxiety in Women Having Breast Biopsies
Diagnosed Young Women Concerned About Fertility Skip Tamoxifen
Black Women Have Higher Rates of Abnormal BRCA Genes Than Previously Thought
Rates of Preventive Double Mastectomy in Men Nearly Doubles
Obesity Changes Breast Tissue, Makes it Easier for Tumors to Grow
ASCO Updates Genetic Testing Policy Statement
Research Confirms Oncotype DX Test Score Between 0 and 10 Means Women Can Skip Chemotherapy
Many Breast Cancers in Sub-Saharan Africa Not Detected Until They’re Advanced-Stage
Computer-Aided Detection May Not Improve Breast Cancer Screening
Research Suggests Olive Oil Linked to Lower Breast Cancer Risk, but There Are Questions About Study
Long-Term Results Show Herceptin Offers More Benefits Than Risks for Early-Stage Breast Cancer
Cancer Survivors’ Diets Are Less Healthy Than Average
New American Cancer Society Breast Cancer Screening Guidelines Recommend Mammograms Start at 45
Research Suggests Menopausal Status Better Than Age for Deciding How Often Women Should Have Mammograms
How Much Does LCIS Diagnosis Increase Risk of Breast Cancer?
Breastfeeding Seems to Reduce Risk of Hormone-Receptor-Negative Disease
People With Lower Incomes Less Likely to Participate in Clinical Trials
Breast Cancer Rates in Black and White Women Now Equal
What Is Risk After Lumpectomy and No Radiation for DCIS?
Minority Women More Likely to Develop Aggressive Disease Than Whites
Study Finds Genomic Differences Between Breast Cancers in Black and White Women
Recurrence Rates After Lumpectomy for DCIS at Memorial Sloan Kettering Have Gone Down Over Time
Study Offers New Reason Why Some Cancers Resistant to Hormonal Therapy
Radiation After Lumpectomy Improves Survival of Older Women Diagnosed With Triple-Negative Disease
Breast Cancer Recurrences May Have Different Genetics Than Primary Tumor
Suppressing Ovaries With Medicine May Help Preserve Fertility After Chemotherapy
Suppressing Ovaries With Medicine May Help Preserve Their Function After Chemotherapy
Most Women Getting Genetic Testing Don’t Get Counseling From Genetics Professional
Advanced Compression Device Seems to Help Treat Lymphedema
High Levels of Immune Cells in HER2-Positive Tumors May Mean Herceptin Not Needed
Information Eases Anxiety About Screening Mammograms
Regular Aerobic Exercise Linked to Less Estrogen-Sensitive Breast Tissue in Premenopausal High-Risk Women
Mammography Detection Rate of High-Grade DCIS Rises With Age
WHO Report Links Processed Meats to Cancer, but It’s Important to Maintain Perspective
Lumpectomy OK for Some Larger Breast Cancers in Older Women
Higher Insulin Levels Linked to Worse Prognosis in Metastatic Breast Cancer
Cancer Survivors Get Fewer Job Interview Callbacks
New Breast Cancer Risk Assessment Tool Aimed at Hispanic Women
Complementary Medicine Techniques Improve Quality of Life in Chinese Cancer Patients
Women Without Prescription Drug Coverage Less Likely to Start Hormonal Therapy
Herceptin Plus Tykerb After Surgery No Better Than Herceptin Alone for Early-Stage, HER2-Positive Disease
Completely Removing Anaplastic Large-Cell Lymphoma Is Best Treatment
False-Positive Mammogram Results May Be Linked to Higher Risk Later in Life
Triple-Negative Disease May Have New Treatment Option
Prolia Reduces Recurrence Risk of Hormone-Receptor-Positive Disease in Women Taking Aromatase Inhibitors
Lumpectomy Plus Radiation May Offer Survival Benefits for Early-Stage Disease
Study Suggests Premenopausal Women With Certain Type of Breast Cancer Don’t Benefit From Chemotherapy
Arimidex or Tamoxifen Reduce Recurrence Risk After DCIS Equally Well in Postmenopausal Women, Choice Depends on Age, Side Effects
Kadcyla Improves Survival in Women Diagnosed With Metastatic, HER2-Positive Disease That’s Stopped Responding to Herceptin and Tykerb
New Guidelines Address Breast Cancer Survivors’ Long-Term Needs
FDA Approves Marketing of DigniCap in United States
Treating Residual Disease With Xeloda Improves Survival in Women With Early-Stage, HER2-Negative Disease
Timely Breast Cancer Treatment Improves Survival
Postmenopausal Women With Gum Disease Seem to Have Higher Breast Cancer Risk
Being Diagnosed at Younger Age Increases Risk of Cancer in Opposite Breast
New Dietary Guidelines Issued, Focus on Dietary Patterns
Detection Rates Similar to Mammograms, Ultrasound May Be Option if Mammography Isn’t Available
If Chemotherapy Before Surgery Destroys All Breast Cancer in Lymph Nodes, Survival Is Better, Especially for Women With HER2-Positive Disease
Breast Density Classification Can Be Unreliable
Experimental Medicine Offers Same Survival Rates as Taxanes as First Treatment for HER2-Negative, Metastatic Disease
Most High-Risk Women Don’t Start or Don’t Finish Preventive Hormonal Therapy
Chemotherapy for Breast Cancer May Increase Risk of Common Infections
For Diagnosed Women, It’s Never Too Late to Quit Smoking
Lipofilling Doesn’t Increase Recurrence Risk
Does Eating Lots of Fiber in High School Really Decrease Breast Cancer Risk?
New Type of Lymph Node Surgery May Allow Some Women to Have Fewer Nodes Removed After Chemotherapy Before Surgery
Rates of BRCA Testing Increasing in Younger Diagnosed Women
Side Effects More Severe in Women Taking Hormonal Therapy After Breast Cancer Surgery
Meditation, Music Help Ease Pain, Anxiety, Fatigue During Breast Biopsy
Prognostic Score May Help Decide Which Women Get Survival Benefits From Radiation After DCIS Surgery
ASCO Issues Guidelines on Using Biomarkers to Make Adjuvant Treatment Decisions for Women Diagnosed With Early-Stage Invasive Disease
Anthracycline Chemotherapy Linked to More Severe Chemo Brain Problems
Abraxane Before Surgery More Beneficial Than Taxol for Early-Stage Disease, but Causes More Side Effects
Experimental Medicine Neratinib Helps Treat Early-Stage, HER2-Positive Disease
Many Younger Women Don’t Think Hormonal Therapy Is Necessary
ASCO Updates Guidelines on Ovarian Suppression After Surgery for Early-Stage, Hormone-Receptor-Positive Disease
Benefits of 3-D Mammograms Last Over Time
Omega-3 Fatty Acids May Reduce Risk in Obese Postmenopausal Women
Faslodex Plus Ibrance Better Than Faslodex Alone for Metastatic, Hormone-Receptor-Positive Disease: Final Analysis of PALOMA-3 Study
About 80% of Women Have PTSD Symptoms After Breast Cancer Diagnosis
Research Confirms Women With Oncotype DX Recurrence Score of 11 or Lower Can Skip Chemotherapy
Early MRI Screening Improves Breast Cancer Survival Rates in Women With Childhood Hodgkin Lymphoma
Does Having Preventive Mastectomy Improve Quality of Life?
Adding 3-D Mammography or Ultrasound to Regular Screening Finds More Cancers in Dense Breasts
Research Suggests Dose-Dense Chemotherapy Improves Survival in Premenopausal Women
Breast Cancer in Men Biologically Different Than Breast Cancer in Women
Response to HER2 Targeted Therapies Seen Just 11 Days After Treatment Starts
Full Dose of Radiation Therapy May Not Be Needed for Some Early-Stage Breast Cancers
Prophylactic Mastectomy Rates Have More Than Tripled in Past Decade
New Breast Cancer Staging System Incorporates HER2 Status
Oncotype DX May Help Make Treatment Decisions for Breast Cancer That’s Metastatic at Diagnosis
Certain Type of PET Scan Detects Recurrence Better Than Traditional Tests
Black Women Less Likely to Have Oncotype DX Testing
Pathologists More Likely to Disagree on Breast Biopsy Results When Diagnosing DCIS
Why Are Women With BRCA1 and BRCA2 Mutations Being Diagnosed at Younger Age?
Ovarian Suppression Plus Tamoxifen Reduces Recurrence Risk Better Than Tamoxifen Alone, but Causes More Severe Side Effects Initially
Acupuncture Helps Ease Hot Flashes
Can Fasting 13 Hours or More at Night Reduce Recurrence Risk?
Aromasin Plus Ovarian Suppression Better Than Tamoxifen for Premenopausal Women With Hormone-Receptor-Positive, HER2-Negative Disease With High Recurrence Risk
Why Are Many Older Women and Black Women Not Treated With Herceptin?
Breast Density Higher in Infertile Women
Experimental Medicine Neratinib Seems to Offer Some Advantages Over Herceptin When Treating Metastatic HER2-Positive Disease
Doctors Miss Some Chemotherapy Side Effects
Low-Fat Diet Linked to Better Breast Cancer Survival for Postmenopausal Women
Kadcyla and Perjeta Before Surgery Offers More Benefits Than Standard Regimen for HER2-Positive Disease
Women Treated With Herceptin Need Heart Monitoring No Matter Their Age
Media Coverage of Celebrities’ Breast Cancer Treatment May Be Contributing to Rise in Double Mastectomies
BRCA1 Mutation Linked to Fewer Eggs in Ovaries
Delaying Radiation After DCIS Surgery Ups Recurrence Risk
Why Do Some HER2-Positive Breast Cancers Not Respond to Herceptin?
Aromatase Inhibitors Increase Risk of Less Serious Heart Problems
Research Suggests MammaPrint Test Can Help Decide Who Can Skip Chemotherapy
Notices About Breast Density Are Hard to Understand
Best Surgery for Early-Stage Disease May Depend on Age
Avastin Slows Metastatic Cancer Growth, but Causes More Side Effects With No Survival Benefit
Expanding Panel Testing Beyond Known Breast/Ovarian Cancer Genes Produces More Questions Than Answers
Changing Order in Which Mammograms Get Second Reading Doesn’t Improve Detection Rates
Two Years of Tamoxifen After Surgery Offers Long-Term Survival Benefits
Black Women Less Likely to Have Genetic Testing Than White Women, but Not Because They See Different Doctors
Black Women With Advanced-Stage Disease Less Likely to Get Certain Supportive Care Medicines Than White Women
Medical Errors Are Third Cause of Deaths in United States
Women Who Use Complementary Medicine Techniques May Be Less Likely to Start Chemotherapy
Immune System-Suppressing Medicines Don’t Seem to Increase Recurrence Risk
Exercise Reduces Risk of Heart Disease in Women With Early-Stage Breast Cancer
10 Years of Femara Better Than 5 for Early-Stage, Hormone-Receptor-Positive Disease
Herceptin Biosimilar Seems as Safe and Effective as Herceptin
Anthracycline Chemo Regimen Seems Better Than Regimen Without Anthracycline for Early-Stage, HER2-Negative, High-Risk Disease
Not Taking Hormonal Therapy as Prescribed Leads to More Recurrence
Oncotype DX Recurrence Score Helps Predict Risk of Late Distant Recurrence
Mindfulness-Based Stress Reduction Program Improves Quality of Life for Diagnosed Women
Women Who Don’t Take Medicine for Other Chronic Conditions Less Likely to Finish Hormonal Therapy
Phase III Results Support Accelerated Approval for Ibrance
Exercise, Maintaining Healthy Weight May Help Reduce Risk of Neuropathy Caused by Chemotherapy
BRCA1 Mutation Linked to Higher Risk of Specific Type of Uterine Cancer
Study Suggests Shorter Radiation Course Better for Many Women With Early-Stage Breast Cancer
Smoking Seems to Make Aromatase Inhibitors Less Effective
Mindfulness-Based Therapy Helps Ease Pain After Breast Cancer Treatment
Age, History of Diabetes Seem to Increase Neuropathy Risk
Dutch Study Shows IVF Doesn’t Increase Breast Cancer Risk
Telephone Genetic Counseling Just As Good As Face-to-Face Counseling
ASCO Issues Guidelines on Hormonal Therapy for Metastatic Breast Cancer
Acupressure Reduces Fatigue in Diagnosed Women
Exercise Eases Memory Problems in Women Treated for Breast Cancer
Being Younger, Axillary Node Surgery Linked to Chronic Pain After Breast Cancer Surgery
No Link Between Stress, Breast Cancer Risk
Overweight Women Have Higher Risk of Heart Problems From Anthracyclines, Herceptin
Oncotype DX Recurrence Score Helps Predict Breast Cancer Survival
Talking to Others Online Linked to More Satisfaction With Treatment Decisions
Mediterranean Diet High in Fat May Reduce Breast Cancer Risk
Do Young Women Have Worse Breast Cancer Outcomes? It Seems to Depend on the Cancer’s Characteristics
Guideline for Lumpectomy Margins for DCIS Issued
Chemotherapy Seems to Increase Risk of Metabolic Syndrome
Expectations May Influence Hormonal Therapy Side Effects, Says Small Study
Breastfeeding, Pregnancy Seem to Improve Breast Cancer Survival
Study Looks at Concerns of Black Women After Treatment
Study Looks at Cost-Effectiveness of Oncotype DX DCIS Test
ASCO Updates Guidelines on Radiation After Mastectomy
Colony-Stimulating Factor Medicines Slightly Lower Hospitalizations for Low White Blood Cell Counts
Hormonal Therapy After Surgery Reduces Risk of Breast Cancer in Opposite Breast in Real-World Setting
Experimental Ribociclib May Help Treat Advanced-Stage, Hormone-Receptor-Positive, HER2-Negative Disease
Faslodex Offers More Benefits Than Arimidex as First Treatment for Women With Advanced-Stage Disease
Fewer Asian Women Have Heart Problems After Herceptin Treatment
MammaPrint Test Can Help Estimate Risk of Recurrence
New Risk Assessment Tool for White Women Includes Common Genetic Variants, but May Be More Useful for Understanding Population Trends
Rates of Breast Cancer About Equal in Blacks and Whites, but Black Women Continue to Have Lower Breast Cancer Survival Rates
Subtype of Metastatic Hormone-Receptor-Positive Disease May Help Guide Treatment Decisions
Study Suggests Hormone-Receptor-Negative Breast Cancer Risk Factors for Young Black Women
One-Third of People Diagnosed With Breast Cancer Not Getting Appropriate Follow-Up Imaging
Older and Younger Women Have Similar Outcomes After Breast Reconstruction
Higher Vitamin D Levels at Diagnosis Linked to Better Breast Cancer Survival
Delays in Follow-Up Imaging More Likely for Women Without Insurance
Online Program Seems to Help Ease Chemo Brain
Testosterone Cream, Vaginal Ring Seem Safe Treatment for Dryness, Loss of Libido
Hormonal Therapy Before Surgery Seems Just as Effective as Chemotherapy Before Surgery for Early-Stage, Hormone-Receptor-Positive Disease
New Guidelines Mean More People Eligible for Accelerated Partial Breast Irradiation
Study Suggests Many Women Don’t Know Breast Density Affects Cancer Risk
3-D Mammograms Improve Detection in Women Younger Than 50
Scalp Cooling System Shown to Reduce Hair Loss During Chemotherapy
Extending Aromatase Inhibitor Use Beyond 5 Years May Benefit Some Women
Study Finds Side Effects of Experimental Buparlisib Too Toxic
Women With More Social Connections Have Better Survival
Older Women Benefit From Screening Mammograms
Tailored Dose-Dense Chemotherapy Doesn’t Seem to Offer More Benefits Than Standard Regimens
Herceptin Biosimilar Seems as Effective as Herceptin
Acupuncture Seems to Help Ease Pain, Nausea, Anxiety After Mastectomy
Follow-Up Care of Latina Breast Cancer Survivors Needs Improvement
FDA Approves Intrarosa for Sexual Symptoms of Menopause
Mammography Should Be Primary Tool to Diagnose Breast Cancer in Men With Symptoms
Electroacupuncture Helps Ease Hot Flashes So Women Sleep Better
Heart Medicines Seem to Reduce Risk of Serious Cardiac Damage in Women Taking Herceptin
Preventive Medicine Helps Ease Diarrhea Side Effects With Neratinib
How Does Radiation Affect Reconstruction Results?
Antidepressant Duloxetine Eases Joint Pain Caused by Aromatase Inhibitors
Adding Afinitor to Faslodex Helps Treat Metastatic Disease That’s AI-Resistant
Breast Cancer Deaths Down in Many Countries
Untreated Long-Term Side Effects of Breast Cancer Treatment Can Lead to Anxiety, Depression
Adding Aromatase Inhibitor to Perjeta and Herceptin Offers Benefits for Advanced-Stage Disease in Early Study
One in Six Women Choose Double Mastectomy
Chemo Brain Can Last for Months After Treatment Ends
Kadcyla Not Better Than Standard of Care as First Treatment for Advanced-Stage, HER2-Positive Disease, but Causes Fewer Side Effects
Exercise Helps Ease Aromatase Inhibitor Side Effects
Anxiety Common Among Partners of Young Women Diagnosed With Breast Cancer
Older Women Report Better Cosmetic Results With Lumpectomy and Brachytherapy
Does Eating Grilled Meat Affect Survival?
Brachytherapy Seems to Offer Similar Cosmetic Results, Fewer Late Side Effects Than Whole Breast Radiation
Breast Cancer Treatment Causes Severe Side Effects in Many Women
Zometa Every 3 Months Seems as Good as Every Month for Women With Bone Metastases After First Year of Treatment
Women Treated for DCIS Live Just as Long as Women With No History of DCIS
Care Improving, but Study Finds Variations in Hormonal Therapy Use After Surgery
Women Who Receive False Positive Mammogram Results May Be More Likely to Delay Next Screening
Many Women at High Risk of Genetic Mutation Don’t Get Testing
Women With Dense Breasts More Likely to Develop Cancer in Opposite Breast
Worsening Hot Flashes, Other Menopausal Symptoms Cause High-Risk Women to Stop Preventive Hormonal Therapy Early
Study Suggests Exercise, Maintaining Healthy Weight Most Important Lifestyle Factors for Reducing Recurrence Risk
Having More Muscle Mass May Mean Milder Chemotherapy Side Effects
Chemotherapy Before Surgery Can Reduce Recurrence Risk in Black Women
Exercise, Psychological Therapy Help Ease Cancer-Related Fatigue Better Than Medicine
Online Therapy Seems to Help Improve Sexual Function in Women Treated for Breast Cancer
Eating Soy Foods May Offer Benefits for Women Diagnosed With Hormone-Receptor-Negative Disease
Adding Experimental Medicine to Xeloda Seems to Improve Metastatic Breast Cancer Outcomes
Kisqali Approved by FDA to Treat Hormone-Receptor-Positive, Advanced-Stage Disease
Diabetes Medicine Linked to Better Outcomes in Diabetics With HER2-Positive, Hormone-Receptor-Positive Breast Cancer
FDA Updates Warning on Link Between Textured Breast Implants and Rare Cancer
Risk of Heart and Lung Problems From Breast Radiation Higher for Smokers
Regular Exercise Before Diagnosis Helps Reduce Risk of Treatment-Related Heart Problems
Long-Term Results Show 1 Year of Herceptin Best for Lowering Recurrence Risk of Early-Stage, HER2-Positive Disease
Women Who Have Immediate Autologous Reconstruction Report Being More Satisfied With Breasts, but Have More Pain 1 Year After Surgery
Doctor’s Recommendation Against Prophylactic Mastectomy Doesn’t Seem to Affect Satisfaction With Surgery Decision
Is There a Link Between High Levels of Air Pollution and Breast Density?
How Closely Are Doctors Following Breast Cancer Screening Guidelines?
Chemo Regimen With Anthracycline Better Than Regimen Without for Early-Stage, HER2-Negative Disease With High Risk of Recurrence
Which Surgery for Early-Stage Breast Cancer Is Most Cost-Effective?
Unclear Explanation of Genetic Testing Results Seems to Affect Treatment Decisions
Some Latina Women Feel Overloaded With Information After Breast Cancer Diagnosis
FDA Approves Marketing of Paxman Scalp Cooling System in United States
Counseling, Treatment Summaries Help Doctors and Patients Better Follow Survivorship Care Plan Recommendations
Society of Integrative Oncology Updates Guidelines on Using Complementary Therapies During and After Breast Cancer Treatment
Study Suggests Link Between Low-Dose Aspirin and Lower Risk for Specific Type of Breast Cancer
More Than Half of Women Don’t Get Enough Information About Reconstruction From Surgeons
More Women Are Living With Metastatic Breast Cancer and Living Longer
Report Adds More Evidence to Link Between Breast Cancer Risk and Drinking Alcohol
Blended Cognitive Behavioral Therapy Can Reduce Fear of Cancer Recurrence
Uninsured Women More Likely to Die From Breast Cancer
Men With BRCA Mutations Have Much Higher Risk of Cancer
Tai Chi Helps Ease Insomnia in Breast Cancer Survivors
Xeloda Improves Survival in Women With Early-Stage, HER2-Negative Disease Who Have Residual Disease After Chemotherapy Before Surgery
Lynparza Better Than Standard Chemotherapy for HER2-Negative Metastatic Breast Cancer in Women With BRCA Mutations
Chemotherapy-Linked Neuropathy Can Affect Balance, Gait Even Years After Treatment Ends
Herceptin Plus Perjeta Slightly Better for High-Risk, HER2-Positive Disease Than Herceptin Alone
Another Biosimilar Seems as Effective as Herceptin
Experimental Abemaciclib Improves Survival in Metastatic, Hormone-Receptor-Positive, HER2-Negative Breast Cancer
Number of Women Needing More Surgery After Lumpectomy Goes Down
New American College of Obstetricians and Gynecologists Guidelines Recommend Women Be Offered Mammograms at Age 40
Final Results From Two Studies Confirm Kadcyla’s Benefits for Advanced-Stage HER2-Positive Disease
Breast Cancer Risk Seems More Affected by Total Body Fat Than Abdominal Fat
Can Eating a Low-Fat Diet Improve Breast Cancer Survival in Postmenopausal Women?
Study Estimates Relative Risk of Breast and Ovarian Cancer for 25 Genetic Mutations
Study Estimates Breast Cancer Risk by Age for Women With BRCA Mutations
North American Menopause Society Updates Position Statement on Hormone Therapy, Says Benefits Outweigh Risks for Some Women
Adding MRI or Ultrasound to Mammograms Improves Detection of New Cancers After Lumpectomy for Younger Women
ASCO Updates Guidelines on Using Biomarkers to Make Adjuvant Treatment Decisions for Women Diagnosed With Early-Stage Invasive Disease to Include MammaPrint Test
Ovarian Suppression After Surgery Causes More Severe Hot Flashes, Night Sweats in Younger Women
Including Risk of Common Genetic Variants May Lead to Better Estimates of Breast and Prostate Cancer Risk in Men With BRCA1/2 Mutations
Triple-Negative Breast Cancer’s Response to Carboplatin Before Surgery Seems Affected By BRCA1/2 Mutation Status
Nerlynx Approved by FDA to Treat Early-Stage, HER2-Positive Breast Cancer
Study Estimates Ashkenazi Jewish Women’s Risk of Having Mutations Other Than BRCA1 and BRCA2
Should Antiperspirants Be Avoided During Radiation Treatment for Breast Cancer?
Exercise Helps Ease Fatigue, Chemo Brain
ASCO Updates Guidelines on Medicines to Control Nausea and Vomiting
Decision-Making Style, Values Influence Surgery Decisions for Early-Stage Breast Cancer
Starting Annual Screening Mammograms at Age 40 Saves More Lives
Using Vaginal Estrogen Not Linked to High Breast Cancer Risk
Review Offers Recommendations for Managing Menopausal Symptoms in Women Who’ve Been Diagnosed With Breast Cancer
Mammogram System That Lets Patients Control Pressure Cleared by FDA
FDA Expands Use of Faslodex for Breast Cancer
Experimental Abemaciclib Improves Outcomes in Advanced-Stage, Hormone-Receptor-Positive Disease
Study Looks at Relationship Between High Cholesterol and Lower Breast Cancer Risk
Full Radiation Dose May Not Be Necessary for Some Early-Stage Breast Cancers
10-Year Results Show That Many Women Don’t Need Axillary Lymph Node Surgery
Location of Fat May Affect Type of Breast Cancer Risk
Exercise Boosts Cognition, Helps Ease Chemo Brain
Tibetan Yoga May Help Women Being Treated With Chemotherapy Sleep Better
FDA Approves Verzenio to Treat Advanced-Stage, Hormone-Receptor-Positive, HER2-Negative Breast Cancer
Cryotherapy May Help Prevent Neuropathy Caused by Taxol Chemotherapy
2017 Breast Cancer Statistics Show Survival Rates Improving
Study Looks at Lymphedema Risk Factors
More Women Having Reconstruction After Mastectomy
Long-Term Use of Insulin Glargine May Be Linked to Higher Risk of Breast Cancer
Health Care Professional’s Recommendation Most Important Factor in Whether Women Take Hormonal Therapy Preventively
Study Suggests Link Between Exposure to Chemicals Early in Life and Breast Cancer Risk
Study Finds 72 New Genetic Mutations Linked to Breast Cancer
Minority Women Less Likely to Have Immediate Breast Reconstruction
ASCO Releases Statement on Alcohol and Cancer Risk
Distant Recurrence Risk of Hormone-Receptor-Positive Breast Cancer Steady 20 Years After Initial Diagnosis
Cymbalta Eases Joint Pain From Aromatase Inhibitors
Overweight Women Likely to Have Larger Breast Cancers at Diagnosis, May Need More Frequent Screening
Women Prefer to Get Mammograms Every Year
FDA Approves Herceptin Biosimilar
Do Hormonal Contraceptives Increase Breast Cancer Risk?
Overweight Postmenopausal Women Who Lose Modest Amount of Weight Have Lower Breast Cancer Risk
Kisqali Can Help Treat Younger Women With Metastatic Hormone-Receptor-Positive Disease
Experimental Talazoparib Seems Better Than Chemotherapy for Metastatic HER2-Negative Disease in Women With a BRCA Mutation
Acupuncture Eases Joint Pain Caused by Aromatase Inhibitors
Temporary Ovarian Suppression May Help Preserve Fertility During Chemotherapy
Extending Aromatase Inhibitor Treatment for 5 More Years No Better Than 2 More Years
Younger Women Report High Rate of Arm Problems 1 Year After Breast Cancer Diagnosis
Very Early Study Hints That Keytruda May Offer Benefits for Certain Metastatic HER2-Positive Breast Cancers
Study Suggests Intensifying Chemotherapy Improves Outcomes for Women With Early-Stage Disease
Combo of Tykerb, Herceptin, and Aromatase Inhibitor Seems Best for Metastatic, HER2-Positive, Hormone-Receptor-Positive Disease
Lynparza Approved to Treat Metastatic HER2-Negative Breast Cancer in Women With BRCA Mutations
Study Estimates Risk of Rare Cancer From Breast Implants
Study Estimates Risks of Radiation Treatment for Breast Cancer in Women With Scleroderma
Two New Genetic Mutations Linked to Higher Risk of Breast Cancer
Exercise Boosts Health of Breast Cancer Survivors
Program Can Help Ease Body Image Concerns and Improve Quality of Life
Yet Another Biosimilar Seems as Safe and as Effective as Herceptin
ASCO Releases Guidelines on Ways to Treat Sexual Problems in People With Cancer
Study Compares Four Genomic Tests for Breast Cancer
FDA Authorizes 23andMe BRCA Genetic Test, but Test Only IDs Three Mutations
Most Newly Diagnosed Women Don’t Receive Genetic Counseling, Even Though They Should Have It
New Guidelines Say Accelerated Whole-Breast Irradiation Should Be Used to Treat Most Breast Cancers
Researchers Identify 110 Genes Associated With Breast Cancer
Scalp Cooling Is Safe, Effective for Reducing Hair Loss Due to Chemotherapy, Study Finds
Black Women Added to High-Risk Group for Breast Cancer
Women With Low Muscle Mass Have Worse Survival
Screening Mammograms Lead to Earlier Stage at Diagnosis, Lower Need for Aggressive Treatment
Family History of Breast Cancer Dramatically Increases Risk of Cancer in Other Breast
Financial Burden of Breast Cancer More Difficult for Black Women
Despite Feeling Unequipped, Many Oncologists Recommend Medical Marijuana for Patients
Writing Program Can Help Ease Body Concerns After Treatment
Most Women Have Multigene Genetic Testing, but Not Until After Surgery
Genetic Testing Criteria May Miss Women With Mutations Linked to Breast Cancer
Early Results Suggest 6 Months of Herceptin as Effective as Treatment for 1 Year
TAILORx Results Suggest About 70% of Women With Early-Stage, Hormone-Receptor-Positive, HER2-Negative Disease Can Skip Chemotherapy
Bioimpedance Spectroscopy Monitoring Plus Self Care Seems to Improve Lymphedema Outcomes
Breast Cancer in Men Has Distinctive Biological Features
Mentally, Physically Demanding Jobs Linked to Unemployment After Breast Cancer Surgery
Breast Reconstruction Decisions Should Be Personalized, Informed By Most Current Data
Is Higher BMI Linked to Lower Breast Cancer Risk for Premenopausal Women?
Advanced-Stage, Triple-Negative Breast Cancer in Women With BRCA1/2 Mutation Seems to Respond Better to Carboplatin Than Taxotere
Can Eating a Low-Fat Diet Improve Breast Cancer Survival in Postmenopausal Women?
Automated Breast Density Measurements Confirm Higher Cancer Risk for Dense Breasts
Is There a Link Between Hormonal Therapy Treatment and Diabetes?
Another Biosimilar Seems as Safe and as Effective as Herceptin
CALM Therapy Helps Ease Depression in People Diagnosed With Advanced-Stage Cancer
Face-to-Face and Internet-Based Counseling Therapy Both Help Ease Fear and Anxiety in People With Cancer
FDA Expands Kisqali’s Uses
Many Women Worried About Paying for Breast Cancer Care, Feel Doctor’s Office Not Helpful
C-Reactive Protein Levels May Help Predict Risk of Severe Skin Side Effects From Radiation
FDA Issues Warning on Laser Treatment for Vaginal Atrophy and Other Menopausal Symptoms
More Than 95% of Public Unaware That Too Little Exercise Increases Cancer Risk
High Number of Certain Skin Cancers Linked to Increased Risk of Breast Cancer
Another Study Looks at Quality of Life After Preventive Mastectomy
Estrogen-Only Hormone Replacement Therapy After Oophorectomy in Women With BRCA1 Mutation Doesn’t Seem to Increase Breast Cancer Risk
How Much Do Mutations in Genes Other Than BRCA1 and BRCA2 Increase Breast and Ovarian Cancer Risk?
Southeastern Women on Medicare Rarely Have Genetic Testing After Being Diagnosed With Breast or Ovarian Cancer
Music Boosts Well-Being of People in Hospice and Palliative Care
Hypnosis Improves Fatigue, Anxiety After Lumpectomy, but Not Pain
Breast Cancer Causes Long-Term Financial Burden for Many People, Especially Those With Lymphedema
Online Calculator Helps Predict Risk of Hormone-Receptor-Positive Breast Cancer Returning Elsewhere in the Body
What Are Risk Factors for Loss of Physical Function After Chemotherapy for Breast Cancer in Older Women?
Physical, Cognitive Function Should Be Considered When Making Breast Cancer Treatment Decisions for Nursing Home Residents
Baseline Heart Imaging Decisions Based on Breast Cancer Treatment Choices, Not Women’s Risk of Cardiac Problems
Herceptin Before Surgery Offers Same Long-Term Benefits When Given At Same Time or After Chemotherapy
MRI Twice per Year May Be Better Than Annual Mammogram for Finding Early Breast Cancers in High-Risk Women
Does Processed Meat Increase Breast Cancer Risk?
Study Shows Value of Second Opinions for Breast Cancer Diagnosis
Silicone Breast Implants Linked to Number of Complications, but FDA Critical of Study
Black Women, Women Living in Poverty Less Likely to Recognize Barriers to Breast Cancer Screening, So They Don’t Take Advantage of Patient Navigation for Optimal Care
Chemo Brain in Older Women May Be Linked to Specific Version of APOE Gene
FDA Approves Talzenna to Treat Metastatic Breast Cancer in Women With BRCA Mutations
Black Women Face Unique Challenges to Sticking With Hormonal Therapy After Breast Cancer Surgery
Immunotherapy Tecentriq Helps Treat Certain Advanced-Stage Triple-Negative Breast Cancers
Adding Ibrance to Faslodex Improves Overall Survival in Advanced-Stage, Hormone-Receptor-Positive Breast Cancer
Is 9 Weeks of Herceptin as Good as 1 Year of Herceptin?
Breast Cancer Risk Assessment Tool Seems Accurate for 19 Years
Mastectomy Doesn’t Eliminate Need for Screening
Many Women Report Paying Out-of-Pocket Costs for Routine Mammograms
Women With Metastatic Breast Cancer Report “Catastrophic” Financial Effects
Long-Term Results Suggest Fat Grafting Does Not Increase Recurrence Risk
Many Younger Women Don’t Take Tamoxifen as Prescribed for Breast Cancer
Radiation Therapy After Surgery for Low-Risk DCIS Reduces Recurrence Risk
No Increase in Long-Term Side Effects With Weekly Hypofractionated Radiation Schedule
Experimental Alpelisib May Help Treat Advanced-Stage, Hormone-Receptor-Positive, HER2-Negative Breast Cancer With Specific Mutation
Zoladex Helps Preserve Fertility in Women With Early-Stage, Hormone-Receptor-Negative Breast Cancer Treated With Chemotherapy
Zometa Plus Femara Seems Better Than Tamoxifen for Premenopausal Women With Hormone-Receptor-Positive Breast Cancer, but Causes More Side Effects
Cold Therapy May Help Prevent Hair Loss, Skin, Nail Side Effects Caused by Taxane Chemotherapy
Regular Screening Reduces Risk of Dying From Breast Cancer
Large Breasts, Chemotherapy Don’t Seem to Rule Out Hypofractionated Radiation Schedule
Women 75 and Older Benefit From Screening Mammograms
Updated ASCO Guidelines Recommend Extended Hormonal Therapy With Aromatase Inhibitors for Postmenopausal Women With Hormone-Receptor-Positive Breast Cancer
Latissimus Dorsi Flap Reconstruction Seems to Cause Biggest Loss in Shoulder Stability, Function
Small Study Suggests App Helps Women Exercise More, Lose Weight After Breast Cancer Diagnosis
Kadcyla Seems Better Than Herceptin for Early-Stage, HER2-Positive Residual Breast Cancer
New Analysis Shows Immunotherapy Tecentriq Only Effective in PD-L1-Positive Breast Cancer
Delaying Chemotherapy More Than 30 Days Linked to Worse Outcomes for Triple-Negative Breast Cancer
Low-Dose Tamoxifen May Be an Option to Reduce Risk of Recurrence, Invasive Disease After Non-Invasive Breast Cancer
Lymph Node Radiation, Surgery Offer Similar Outcomes After Positive Sentinel Node in Early-Stage Breast Cancer
Accelerated Partial-Breast Radiation Slightly Less Effective Than Whole-Breast Radiation for Preventing Breast Cancer Recurrence After Lumpectomy
Regular Exercise During Treatment After Breast Cancer Surgery Offers Benefits
Overactive Bladder Medicine Helps Ease Hot Flashes in Women Treated for Breast Cancer
Surgery Choice for Early-Stage Breast Cancer Seems to Affect Younger Women’s Quality of Life
BMI Not Best Measure of Body Fat When Estimating Breast Cancer Risk in Postmenopausal Women
FDA Approves Herceptin Biosimilar Herzuma for HER2-Positive Breast Cancer
TAILORx Data Suggest Race Can Affect Breast Cancer Outcomes
Current Breast Cancer Genetic Testing Guidelines Leave Out Many People With Harmful Mutations
Breast Cancer Protection From Childbirth Starts Later Than Thought
Multi-Gene Genetic Tests Don’t Cause More Worry Than BRCA Testing Alone in Women Diagnosed With Breast Cancer
Self-Administered Acupressure Helps Ease Anxiety, Pain, Depression After Breast Cancer Treatment
Is Breast Cancer Linked to Higher Risk of Atrial Fibrillation?
Hope, Positivity, Family Support Help People With Advanced-Stage Cancer Live Well
FDA Approves Herceptin Biosimilar Ontruzant for HER2-Positive Breast Cancer
Mammograms Are Less Painful, Just as Effective When Women Control Compression
Men Treated With Tamoxifen for Breast Cancer Have Higher Risk of Blood Clots
Mammograms, Breast Cancer Treatment Advances Have Saved Hundreds of Thousands of Lives in Last 30 Years
Online Therapy Helps Ease Effects of Hot Flashes and Night Sweats Caused by Breast Cancer Treatment
Older Biological Age Compared to Chronological Age Linked to Increased Breast Cancer Risk
The Glass Is Half Full: Women Have Many More Positive Than Negative Thoughts About Changes Due to Breast Cancer
FDA Approves Injectable Herceptin for HER2-Positive Breast Cancer
Women Who’ve Experienced Breast Cancer Suggest Changes to Ease Financial Burden of Disease
Tecentriq Approved as First Immunotherapy for Breast Cancer
FDA Issues Warning About Robotic Mastectomies, Other Cancer Surgeries
FDA Approves Herceptin Biosimilar Trazimera to Treat HER2-Positive Breast Cancer
Group Exercise Improves Quality of Life More Than Personal Training for Women Treated for Breast Cancer
3D Mammography More Likely to Find Small Invasive Breast Cancers, Especially in Women Younger Than 50
Immigrant Asian Women Seem to Have Higher Risk of Breast Cancer Compared to U.S.-Born Asian Women
High Out-of-Pocket Costs Lead to Delays in Breast Cancer Care for Low-Income Women
Formal Treatment Guidelines Developed for Rare Cancer Linked to Breast Implants
FDA Warns Two Breast Implant Makers About Lack of Long-Term Studies, Will Review Implant Safety
Advanced Breast Cancer Screening Methods Classify Fewer Women as Having Dense Breasts
3D Mammography Reduces Breast Biopsy Rates
FDA Says Mammography Reports Should Provide More Information on Breast Density
Faslodex and Arimidex Better Than Arimidex Alone as First Treatment for Hormone-Receptor-Positive Metastatic Breast Cancer
Exercise Reduces Risk of Heart Disease in Women Treated for Early-Stage Breast Cancer
Ibrance Approved to Treat Men With Advanced-Stage Hormone-Receptor-Positive Breast Cancer
Surgery Linked to Better Survival for Metastatic HER2-Positive Breast Cancer
Breast Surgeons Group Says Everyone Diagnosed With Breast Cancer Should Be Offered Genetic Testing
3D Mammograms More Effective Than 2D Mammograms in Women 65 and Older
More Than 20% of Women Diagnosed With Early-Stage Breast Cancer Stop Follow-Up Care Early
Switching to New Doctor Delays Breast Cancer Treatment
Genetic Testing Rates Are Low in Women Diagnosed With Breast Cancer, Ovarian Cancer
Nutrients From Food, Not Supplements, Linked to Lower Risk of Death, Cancer
Having a Partner Seems to Improve Quality of Life in Women With Sexual Side Effects From Breast Cancer Hormonal Therapy
Radiation Therapy Benefits All Early-Stage Hormone-Receptor-Positive Breast Cancer
Six Factors Linked to Invasive Breast Cancer Recurrence After DCIS
Kadcyla Approved to Treat Early-Stage HER2-Positive Breast Cancer
Chemotherapy Break Linked to Worse Outcomes for Advanced-Stage HER2-Negative Breast Cancer
Bioimpedance Spectroscopy Seems Better Than Tape Measure for Detecting Lymphedema Early
American Society of Breast Surgeons Issues Updated Breast Cancer Screening Guidelines
Feminizing Hormones Linked to Higher Breast Cancer Risk in Trans Women, but Risk Still Lower Than Average Woman’s
Does a Low-Fat Diet Reduce the Risk of Dying From Breast Cancer?
FDA Approves Piqray to Treat Advanced-Stage Hormone-Receptor-Positive, HER2-Negative Breast Cancer With PIK3CA Mutation
Adding Kisqali Improves Overall Survival in Younger Women With Advanced-Stage Hormone-Receptor-Positive Breast Cancer
Can Treatment Regimens Before Surgery for Early-Stage HER2-Positive Breast Cancer Omit Chemotherapy?
Experimental Margetuximab May Help Treat Certain HER2-Positive Metastatic Breast Cancers
Adding Clinical Risk of Recurrence to Oncotype DX Score Can Help Make Chemotherapy Decisions for Younger Women With Early-Stage Breast Cancer
Patients Report Less Fatigue, More Convenience, Slightly Worse Cosmetic Outcomes With Partial-Breast vs. Whole-Breast Radiation
MRI Finds Breast Cancer at Earlier Stage Than Mammograms in High-Risk Women, but May Result in More False Positives
Combining Breast Density Info With 5-Year Breast Cancer Risk Score Helps Determine Which Women Need Additional Screening
Ashkenazi Jewish Women Who Know They Have BRCA Mutation Have Better Breast Cancer Outcomes
Childhood Cancer Linked to Worse Mortality After Breast Cancer
Herceptin Biosimilar for Breast Cancer Now Available in U.S. Market
Allergan Issues Worldwide Recall of Biocell Textured Breast Implants and Tissue Expanders
Delaying Chemotherapy More Than 120 Days After Diagnosis Linked to Worse Survival for Early-Stage Breast Cancer
ASCO Updates Guidelines on Using Biomarkers to Make Adjuvant Treatment Decisions for Women Diagnosed With Early-Stage Invasive Breast Cancer
Using MRI to Follow Previously Diagnosed Women Finds More Breast Cancers, but Leads to More Biopsies
Abdominal and Intramuscular Fat Increase Risk of Heart Disease in Breast Cancer Survivors
Preventive Ovary Removal in Women With BRCA Mutation Leads to Lower Bone Density
Task Force Expands BRCA Genetic Testing Recommendations; More Women Will Be Referred for Counseling and Testing
Home-Based Weight Loss, Exercise Programs Don’t Help Breast Cancer-Related Lymphedema
Receiving Less Than 85% of Planned Chemotherapy Dose Affects Early-Stage Breast Cancer Survival
FDA Says Men Should Be in Breast Cancer Studies
Small Study Finds High Rate of Gene Mutations in People Diagnosed With Metastatic Breast Cancer
In Appropriate Women, Nipple-Sparing Mastectomy Doesn’t Lead to Higher Breast Cancer Recurrence Rates
Updated ASCO Guidelines Add Arimidex to Recommended Risk-Reducing Medicines for Women at High Risk of Breast Cancer
FDA Warns About Rare but Severe Lung Inflammation Linked to Breast Cancer Drugs Ibrance, Kisqali, and Verzenio
FDA Warns About Probable Carcinogen in Zantac
Men at High Risk for Breast Cancer Benefit From Mammograms
Men With Breast Cancer Have Lower Survival Rates Than Women
Adding 2 Years of Ovarian Suppression to Tamoxifen Improves Survival in Premenopausal Women With Early-Stage Breast Cancer
Verzenio Plus Faslodex Improves Overall Survival by 9 Months in Advanced-Stage, Hormone-Receptor-Positive, HER2-Negative Breast Cancer
Kisqali Plus Faslodex Improves Overall Survival in Advanced-Stage, Hormone-Receptor-Positive, HER2-Negative Breast Cancer
Adding Keytruda to Chemotherapy Before Surgery for Early-Stage, Triple-Negative Breast Cancer Improves Response to Treatment
Multigene Testing of Everyone Diagnosed With Breast Cancer Deemed Cost-Effective, and Researchers Say Policies Should Change
Low Vitamin D Levels Found in Irish Women Diagnosed With Breast Cancer
Treatment of Male Breast Cancer Has Evolved, Study Shows
Experts Update Exercise Guidelines for People Treated for Cancer
Sentinel Lymph Node Biopsy Offers No Benefits for Older Women With DCIS
CDK4/6 Inhibitor Plus Aromatase Inhibitor Helps Treat Breast Cancer, No Matter a Woman’s Age
Supplemental MRI Screening May Benefit Women With Extremely Dense Breasts
Permanent Hair Dyes, Straighteners Linked to Higher Breast Cancer Risk
Experimental Tucatinib Improves Survival in Metastatic HER2-Positive Breast Cancer, May Be New Standard of Care
Immunotherapy for Early-Stage Triple-Negative Breast Cancer: Understanding What Appear to Be Conflicting Results
Risk-Reducing Effects of Arimidex for High-Risk Postmenopausal Women Last Years After Treatment Stops
Subcutaneous Herceptin and Perjeta Combined With Chemo Before Breast Cancer Surgery Offers Same Benefits as IV Versions
Is Oral Paclitaxel Better Than IV Paclitaxel for Metastatic Breast Cancer?
FDA Approves Enhertu for Unresectable or Pretreated Metastatic HER2-Positive Breast Cancer
Adding Perjeta to Herceptin and Chemotherapy After Surgery Shows Benefits in Early-Stage HER2-Positive Breast Cancer
Breast Cancers Found by Yearly Mammograms Smaller, Less Advanced Than Cancers Found by Mammograms Every 2 Years
Study Links Sustained Weight Loss After 50 to Lower Breast Cancer Risk
At-Home Genetic Tests Miss Many Mutations Linked to Cancer, Especially in Ethnic Minorities
U.S. Black Men Have Higher Rates of All Types of Breast Cancer Compared to White Men
Taking Certain Supplements Before and During Chemotherapy for Breast Cancer May Be Risky
Long-Term Follow-Up Suggests Estrogen-Only and Combination Hormone Replacement Therapy Have Opposite Effects on Breast Cancer Risk
Estrogen-Receptor-Negative, Progesterone-Receptor-Positive Breast Cancers: A Distinct Subtype?
Racial Disparities in Breast Cancer Stage at Diagnosis Linked to Lack of Insurance
More Evidence That Chemotherapy Before Surgery Can Make Triple-Negative Breast Cancer Eligible for Lumpectomy
FDA Says Diet Medicine Belviq Seems to Be Linked to Increase in Cancer Risk

Email Updates